Advisory Alpha’s Boston Scientific BSX Stock Holding History

Advisory Alpha’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$501K	Buy	11,728 +3,114	+36%	+$169K	0.01%	371
2026 Q1	$541K	Sell	8,614 -404	-4%	-$32.3K	0.01%	311
2025 Q4	$860K	Buy	9,018 +584	+7%	+$57.3K	0.02%	213
2025 Q3	$812K	Buy	8,434 +1,575	+23%	+$163K	0.02%	215
2025 Q2	$737K	Buy	6,859 +860	+14%	+$87K	0.02%	209
2025 Q1	$605K	Buy	5,999 +552	+10%	+$55.6K	0.02%	220
2024 Q4	$487K	Sell	5,447 -62	-1%	-$5.46K	0.02%	237
2024 Q3	$462K	Buy	5,509 +10	+0.2%	+$788	0.02%	250
2024 Q2	$423K	Buy	5,499 +113	+2%	+$8.27K	0.02%	236
2024 Q1	$369K	Buy	+5,386	New	+$346K	0.02%	258
2019 Q4	–	Sell	-60	Closed	-$2.32K	–	773
2019 Q3	$2.32K	Buy	+60	New	+$2.54K	﹤0.01%	632
2019 Q2	–	Sell	-21	Closed	-$778	–	179
2019 Q1	$778	Buy	+21	New	+$802	﹤0.01%	615

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Advisory Alpha's BSX Position: Q2 2026 in Review

Advisory Alpha increased its Boston Scientific (BSX) stake by 36% in Q2 2026, buying an estimated $169K and bringing the position to 11,728 shares worth $501K. The position accounts for 0.01% of the portfolio, ranked #371.

Advisory Alpha first reported a position in BSX in Q1 2019 and has held it in 12 quarters since. The position peaked at $860K in Q4 2025. 1,477 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

Advisory Alpha held 11,728 shares of Boston Scientific worth $501K as of Q2 2026.
Advisory Alpha bought 3,114 Boston Scientific shares in Q2 2026, an estimated $169K.
Boston Scientific made up 0.01% of Advisory Alpha's portfolio in Q2 2026, its #371 holding.
Advisory Alpha first reported a position in Boston Scientific in Q1 2019 and has held it in 12 quarters since.
Advisory Alpha's Boston Scientific position peaked at $860K in Q4 2025.
1,477 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Advisory Alpha's 13F filing for Q2 2026, filed 11 Aug 2026.